NASDAQ:PRVA Privia Health Group (PRVA) Stock Price, News & Analysis $23.48 +0.07 (+0.30%) As of 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Privia Health Group Stock (NASDAQ:PRVA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Privia Health Group alerts:Sign Up Key Stats Today's Range$22.87▼$23.6650-Day Range$21.48▼$25.6952-Week Range$15.92▼$26.04Volume715,313 shsAverage Volume772,769 shsMarket Capitalization$2.85 billionP/E Ratio234.82Dividend YieldN/APrice Target$27.14Consensus RatingBuy Company OverviewPrivia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.Read More… Privia Health Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks82nd Percentile Overall ScorePRVA MarketRank™: Privia Health Group scored higher than 82% of companies evaluated by MarketBeat, and ranked 284th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingPrivia Health Group has received a consensus rating of Buy. The company's average rating score is 3.07, and is based on 12 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoveragePrivia Health Group has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Privia Health Group's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth92.86% Earnings GrowthEarnings for Privia Health Group are expected to grow by 92.86% in the coming year, from $0.14 to $0.27 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Privia Health Group is 234.82, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.74.Price to Earnings Ratio vs. SectorThe P/E ratio of Privia Health Group is 234.82, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.42.Price to Earnings Growth RatioPrivia Health Group has a PEG Ratio of 3.47. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioPrivia Health Group has a P/B Ratio of 4.57. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Privia Health Group's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.24% of the float of Privia Health Group has been sold short.Short Interest Ratio / Days to CoverPrivia Health Group has a short interest ratio ("days to cover") of 4.3.Change versus previous monthShort interest in Privia Health Group has recently decreased by 16.55%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPrivia Health Group does not currently pay a dividend.Dividend GrowthPrivia Health Group does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted3.24% of the float of Privia Health Group has been sold short.Short Interest Ratio / Days to CoverPrivia Health Group has a short interest ratio ("days to cover") of 4.3.Change versus previous monthShort interest in Privia Health Group has recently decreased by 16.55%, indicating that investor sentiment is improving significantly. News and Social Media4.1 / 5News Sentiment1.34 News SentimentPrivia Health Group has a news sentiment score of 1.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.85 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 13 news articles for Privia Health Group this week, compared to 4 articles on an average week.Search Interest3 people have searched for PRVA on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat Follows4 people have added Privia Health Group to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Privia Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $125,999.00 in company stock.Percentage Held by Insiders10.70% of the stock of Privia Health Group is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions94.48% of the stock of Privia Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Privia Health Group's insider trading history. Receive PRVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter. Email Address PRVA Stock News HeadlinesDavid Mountcastle Sells 5,630 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) StockApril 4, 2025 | insidertrades.comIs Privia Health Group, Inc.'s (NASDAQ:PRVA) Recent Stock Performance Influenced By Its Financials In Any Way?April 29 at 3:10 PM | finance.yahoo.comURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold. April 30, 2025 | Golden Portfolio (Ad)Privia Health Group (NASDAQ:PRVA) Receives Market Outperform Rating from JMP SecuritiesApril 29 at 3:43 AM | americanbankingnews.comBrokerages Set Privia Health Group, Inc. (NASDAQ:PRVA) Price Target at $27.00April 21, 2025 | americanbankingnews.com1PRVA : Assessing Privia Health Gr: Insights From 10 Financial AnalystsApril 15, 2025 | benzinga.comPrivia Health price target raised to $26 from $24 at BairdApril 15, 2025 | markets.businessinsider.comPrivia Health price target lowered to $28 from $30 at TruistApril 10, 2025 | markets.businessinsider.comSee More Headlines PRVA Stock Analysis - Frequently Asked Questions How have PRVA shares performed this year? Privia Health Group's stock was trading at $19.55 at the start of the year. Since then, PRVA stock has increased by 20.1% and is now trading at $23.48. View the best growth stocks for 2025 here. How were Privia Health Group's earnings last quarter? Privia Health Group, Inc. (NASDAQ:PRVA) issued its quarterly earnings data on Thursday, August, 8th. The company reported $0.03 earnings per share for the quarter, missing analysts' consensus estimates of $0.05 by $0.02. Privia Health Group's revenue was up 2.2% compared to the same quarter last year. Read the conference call transcript. When did Privia Health Group IPO? Privia Health Group (PRVA) raised $351 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 19,500,000 shares at $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair acted as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers. Who are Privia Health Group's major shareholders? Top institutional investors of Privia Health Group include Riverbridge Partners LLC (4.55%), Principal Financial Group Inc. (2.44%), Bank of New York Mellon Corp (1.82%) and Envestnet Asset Management Inc. (0.48%). Insiders that own company stock include Adam Boehler, William M Sullivan, Jeffrey B Butler, Parth Mehrotra, David Mountcastle, Advisors LLC Mbd, Thomas Bartrum, Matthew Shawn Morris and Thomas A Mccarthy. View institutional ownership trends. How do I buy shares of Privia Health Group? Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Privia Health Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Privia Health Group investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), TotalEnergies (TTE) and Southern First Bancshares (SFST). Company Calendar Last Earnings8/08/2024Today4/30/2025Next Earnings (Estimated)5/08/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryHealthcare Current SymbolNASDAQ:PRVA CIK1759655 Webwww.priviahealth.com Phone571-366-8850FaxN/AEmployees810Year FoundedN/APrice Target and Rating Average Stock Price Target$27.14 High Stock Price Target$40.00 Low Stock Price Target$20.00 Potential Upside/Downside+16.1%Consensus RatingBuy Rating Score (0-4)3.07 Research Coverage15 Analysts Profitability EPS (Most Recent Fiscal Year)$0.11 Trailing P/E Ratio233.72 Forward P/E Ratio166.93 P/E Growth3.47Net Income$23.08 million Net Margins0.75% Pretax Margin1.41% Return on Equity2.02% Return on Assets1.21% Debt Debt-to-Equity RatioN/A Current Ratio1.78 Quick Ratio1.78 Sales & Book Value Annual Sales$1.74 billion Price / Sales1.63 Cash Flow$0.24 per share Price / Cash Flow98.24 Book Value$5.14 per share Price / Book4.55Miscellaneous Outstanding Shares121,313,000Free Float102,961,000Market Cap$2.84 billion OptionableOptionable Beta0.88 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (NASDAQ:PRVA) was last updated on 4/30/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Privia Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Privia Health Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.